Aptitude said Tuesday that the U.S. Food and Drug Administration granted 510(k) clearance for its next-generation Metrix COVID Test, marking the company’s first such clearance and moving the product line further from emergency authorization. The new test is designed to give results about 30% faster than the original EUA-authorized version while delivering roughly three times greater analytical sensitivity.
The timing matters because demand for COVID-19 tests tends to rise as respiratory season approaches, and Aptitude said it does not expect a disruption in availability. Metrix products are already broadly available through major distributors with Sekisui Diagnostics, and customers can keep buying them as the transition continues. JP Wang said, “We’re continually developing Metrix to make it better,” adding that FDA clearance is “an important step, not a stopping point.”
That clearance also lands as the regulatory clock is ticking. The COVID-19 EUA declarations for medical devices are scheduled to end on Dec. 26, 2026, which pushes products like Metrix toward the traditional clearance pathway. Metrix is already FDA-cleared for over-the-counter and professional use in CLIA-waived settings, and development of the platform has been backed by the Biomedical Advanced Research and Development Authority.
There is a practical catch in the handoff. Aptitude said previously distributed Metrix EUA-authorized products may still be used through their labeled expiration dates, so the old and new versions will overlap for a while rather than flip overnight. That gives clinics and distributors room to adjust, but it also means the company has to run two regulatory realities at once: one product already cleared, another still under review, and a respiratory lineup that is not finished moving. Aptitude said its next-generation Metrix COVID/Flu Test is under FDA review for 510(k) clearance, while other products targeting RSV, Strep and sexually transmitted infections remain in late-stage development or under review.
For JP Wang, the clearance is a milestone, not the finish line. He said the company will keep pushing Metrix forward with faster tests, better performance, simpler operations and a broader menu, and the next question is how quickly Aptitude can turn that promise into more cleared products before the EUA era closes for good.
